OncoMark Overview
- Founded
- 2007
- Status
- Private
- Employees
- 11
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $2.25M
- Investors
- 6
OncoMark General Information
Description
Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The company's device detects early stage breast cancer by measuring the expression of 3 prognostic genes (+ 3 reference genes) and estimates the probability of distant recurrence for breast cancer patients, enabling clinicians to determine treatment options for their patients and ultimately improving the patent's quality of life.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- NovaUCD, Belfield Innovation Park
- Belfield
- Dublin 4
- Ireland
+353 (01) 000 0000
OncoMark Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 15-Feb-2017 | $2.25M | 00.000 | Completed | Generating Revenue | |
| 2. Grant | 09-Sep-2015 | 00.000 | Completed | Startup | ||
| 1. Grant | $3.89M | Completed | Startup |
OncoMark Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The compan
Diagnostic Equipment
Dublin, Ireland
11
As of 2018
00.000
0000000000 0
00.000
0000000
esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000000000000 00000000
Boston, MA
00
As of 0000
000.00
00000000000
000.00
00000000
mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
0000000000000
Gaithersburg, MD
00
As of 0000
000.00
000
0000-00-00
00000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialOncoMark Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Farcast Biosciences | Venture Capital-Backed | Boston, MA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Gaithersburg, MD | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000 00000 |
OncoMark Executive Team (6)
OncoMark Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cormac Kilty Ph.D | Self | Board Member | 000 0000 |
| Desmond O'Leary | OncoMark | Chief Executive Officer & Board Member | 000 0000 |
| Donal O'Shea Ph.D | Self | Board Member | 000 0000 |
| Stephen Penney | OncoMark | Co-Founder, Board Member & Company Secretary | 000 0000 |
| William M. Gallagher | OncoMark | Co-Founder, Chairman & Chief Scientific Officer | 000 0000 |
OncoMark Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOncoMark Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Enterprise Ireland | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Halo Business Angel Network | Angel Group | Minority | 000 0000 | 000000 0 | |
| Irrus Investments | Angel Group | Minority | 000 0000 | 000000 0 | |
| Kernel Capital (Ireland) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Horizon 2020 | Government | 000 0000 | 000000 0 |